| Dr Nicholas Jackson Hardin, MD | |
|
111 Colchester Ave, Burlington, VT 05401-1473 | |
| (802) 847-2795 | |
| (802) 847-9644 |
| Full Name | Dr Nicholas Jackson Hardin |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073543757 | NPI | - | NPPES |
| 00048301 | Medicaid | VT | |
| 00787444 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 042-0005931 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nicholas Jackson Hardin, MD 20 Tree Hill Rd, Williston, VT 05495-9041 Ph: (802) 878-8458 | Dr Nicholas Jackson Hardin, MD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-2795 |
News Archive
More than half the counties in America have no intensive care beds, posing a particular danger for more than 7 million people who are age 60 and up - older patients who face the highest risk of serious illness or death from the rapid spread of COVID-19, a Kaiser Health News data analysis shows.
Using CT scans to measure blood flow in the lungs of people who smoke may offer a way to identify which smokers are most at risk of emphysema before the disease damages and eventually destroys areas of the lungs, according to a University of Iowa study.
USA Today reports on how, in states that opted not to pursue the health law's Medicaid expansion, many of the poorest residents may fall through the cracks. Meanwhile, the San Jose Mercury News looks at some of the states that have been the most resistant to implementing the health law.
Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited announced that its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc. has resubmitted New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for alogliptin and fixed-dose combination therapy alogliptin and pioglitazone for the treatment of type 2 diabetes in adults.
› Verified 2 days ago
Dr. Laura Aman Greene, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Ep-2-113, Burlington, VT 05401 Phone: 802-847-3566 Fax: 802-847-4155 | |
Dr. Pamela Cox Gibson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-3989 Fax: 802-847-9644 | |
Dr. Mark K Fung, MD, PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fletcher Allen Health Care - Pathology, Burlington, VT 05401 Phone: 802-847-3000 Fax: 802-847-3509 | |
Dr. Siba El Hussein, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-5121 | |
Ms. Allison Leigh Ciolino, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-5121 | |
Dr. John H Lunde, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fletcher Allen Health Care, Pathology, Burlington, VT 05401 Phone: 802-847-5135 Fax: 802-847-3987 |